Remove Food and Drug Administration Remove Leads Remove Pharmaceutical products Remove Physicians
article thumbnail

Pharma within planetary boundaries

European Pharmaceutical Review

In addition, the number of active substances detected in the environment has been increasing with unknown consequences for ecosystems and the accumulation of substances in food chains. Giving environmental risk assessments teeth Since 2005, the authorisation of a human pharmaceutical product requires an environmental risk assessment (ERA).

Pharma 81
article thumbnail

Uri Goren

Cadensee

Basically, I started teaching myself how to get good information outside the internet and see how that empowers us with our discussion with a physician with everything that we did. It might be silly question but bringing a drug to market takes many, many years. So, I myself, was kind of tasked with go and search on the internet.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”. 1 Following in vitro production from T cells collected from a patient’s leukapheresis procedure, the CAR T cells are infused back into the patient’s blood, where they proliferate and expand.